Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MBX-2109 by MBX Biosciences Inc for Hypoparathyroidism: Likelihood of Approval
MBX-2109 is under clinical development by MBX Biosciences Inc and currently in Phase I for Hypoparathyroidism. According to GlobalData, Phase I...
MBX-1416 by MBX Biosciences Inc for Hypoglycemia: Likelihood of Approval
MBX-1416 is under clinical development by MBX Biosciences Inc and currently in Phase I for Hypoglycemia. According to GlobalData, Phase I...
MBX-2109 by MBX Biosciences Inc for Hypoparathyroidism: Likelihood of Approval
MBX-2109 is under clinical development by MBX Biosciences Inc and currently in Phase II for Hypoparathyroidism. According to GlobalData, Phase II...